Thu, September 15, 2022
Wed, September 14, 2022
Tue, September 13, 2022

Matthew Harrison Maintained (AKRO) at Hold with Increased Target to $30 on, Sep 14th, 2022

Matthew Harrison of Morgan Stanley, Maintained "Akero Therapeutics, Inc." (AKRO) at Hold with Increased Target from $26 to $30 on, Sep 14th, 2022.

Matthew, nor any peers, have made any analyst calls on AKRO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30